- TRIM26 INHIBITS HEPATITIS B VIRUS REPLICATION BY PROMOTING HBx DEGRADATION AND TRIM26 GENETIC POLYMORPHISM PREDICTS PEGIFNA TREATMENT RESPONSE OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTSLuo, Mengqi; Jiang, Deke
- Rs117648444 nonsynonymous variant in INFL4 gene impacts on HCV RNA decline during the first 4 weeks of Pegylated Interferon and Ribavirin therapy in HCV-1 IL28B rs12979860 CT/TT patientsGalmozzi Enrico; Aghemo Alessio; Degasperi Elisabetta; D'Ambrosio Roberta; Soffredini Roberta; Grassi Eleonora; De Nicola Stella; Colombo Massimo64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.
- Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of responseCetin Karaca; Ozlem Mutluay Soyer; Bulent Baran; Asli Cifcibasi Ormeci; Suut Gokturk; Esra Aydin; Sami Evirgen; Filiz Akyuz; Kadir Demir; Fatih Besisik; Sabahattin KaymakogluAntiviral Therapy, 2012, 18(4): 561-566.
会议论文
EXPLORING THE ROLE OF A CD40 FUNCTIONAL VARIANT IN HBV CLEARANCE REVEALS A NOVEL PREDICTOR OF PEGIFNα TREATMENT RESPONSE
4阅读
